FDA allowance to export the cartridges made at our San Diego plant was the final regulatory hurdle we needed to overcome in order to start treating patients in our pivotal clinical trial in China. Personnel are now being trained and cartridges manufactured so we can begin patient treatment early in 2006.
Terry Winters